We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
Read MoreHide Full Article
Thermo Fisher Scientific (TMO - Free Report) closed at $528.50 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's daily gain of 0.1%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.06%.
Prior to today's trading, shares of the maker of scientific instrument and laboratory supplies had lost 1.14% over the past month. This has lagged the Medical sector's gain of 1.23% and was narrower than the S&P 500's loss of 3.6% in that time.
Investors will be hoping for strength from Thermo Fisher Scientific as it approaches its next earnings release. In that report, analysts expect Thermo Fisher Scientific to post earnings of $5.19 per share. This would mark a year-over-year decline of 20.64%. Our most recent consensus estimate is calling for quarterly revenue of $10.36 billion, down 3.21% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.04 per share and revenue of $43.82 billion, which would represent changes of -8.32% and +11.76%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Thermo Fisher Scientific. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Thermo Fisher Scientific is currently sporting a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Thermo Fisher Scientific has a Forward P/E ratio of 23.01 right now. For comparison, its industry has an average Forward P/E of 29.81, which means Thermo Fisher Scientific is trading at a discount to the group.
It is also worth noting that TMO currently has a PEG ratio of 1.84. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. TMO's industry had an average PEG ratio of 2.08 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 84, which puts it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
Thermo Fisher Scientific (TMO - Free Report) closed at $528.50 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's daily gain of 0.1%. At the same time, the Dow added 0.28%, and the tech-heavy Nasdaq lost 0.06%.
Prior to today's trading, shares of the maker of scientific instrument and laboratory supplies had lost 1.14% over the past month. This has lagged the Medical sector's gain of 1.23% and was narrower than the S&P 500's loss of 3.6% in that time.
Investors will be hoping for strength from Thermo Fisher Scientific as it approaches its next earnings release. In that report, analysts expect Thermo Fisher Scientific to post earnings of $5.19 per share. This would mark a year-over-year decline of 20.64%. Our most recent consensus estimate is calling for quarterly revenue of $10.36 billion, down 3.21% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.04 per share and revenue of $43.82 billion, which would represent changes of -8.32% and +11.76%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Thermo Fisher Scientific. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Thermo Fisher Scientific is currently sporting a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Thermo Fisher Scientific has a Forward P/E ratio of 23.01 right now. For comparison, its industry has an average Forward P/E of 29.81, which means Thermo Fisher Scientific is trading at a discount to the group.
It is also worth noting that TMO currently has a PEG ratio of 1.84. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. TMO's industry had an average PEG ratio of 2.08 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 84, which puts it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.